# Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

> **NCT02212327** · — · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 41 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02212327
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-11-29
- **Final completion:** 2016-11-29
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2019-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02212327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02212327, "Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02212327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*